BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,080 filers reported holding BAXTER INTL INC in Q3 2020. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $377,842 | -20.1% | 10,012 | -3.6% | 0.01% | -14.3% |
| Q2 2023 | $473,152 | +3.7% | 10,385 | -7.7% | 0.01% | 0.0% |
| Q1 2023 | $456,431 | -42.6% | 11,253 | -27.9% | 0.01% | -46.2% |
| Q4 2022 | $795,399 | -18.1% | 15,605 | -13.5% | 0.01% | -27.8% |
| Q3 2022 | $971,000 | -15.1% | 18,034 | +1.2% | 0.02% | -18.2% |
| Q2 2022 | $1,144,000 | -17.2% | 17,818 | 0.0% | 0.02% | -4.3% |
| Q1 2022 | $1,382,000 | -9.0% | 17,818 | +0.8% | 0.02% | -4.2% |
| Q4 2021 | $1,518,000 | +21.0% | 17,685 | +13.3% | 0.02% | 0.0% |
| Q3 2021 | $1,255,000 | +5.6% | 15,609 | +5.8% | 0.02% | 0.0% |
| Q2 2021 | $1,188,000 | -9.4% | 14,754 | -5.1% | 0.02% | -17.2% |
| Q1 2021 | $1,311,000 | +23.0% | 15,547 | +17.0% | 0.03% | +7.4% |
| Q4 2020 | $1,066,000 | +4.1% | 13,284 | +4.3% | 0.03% | -10.0% |
| Q3 2020 | $1,024,000 | -6.1% | 12,737 | +0.5% | 0.03% | -11.8% |
| Q2 2020 | $1,091,000 | +6.9% | 12,672 | +0.7% | 0.03% | -19.0% |
| Q1 2020 | $1,021,000 | -4.9% | 12,581 | -2.0% | 0.04% | +20.0% |
| Q4 2019 | $1,074,000 | -4.2% | 12,839 | +0.1% | 0.04% | -30.0% |
| Q3 2019 | $1,121,000 | +6.8% | 12,820 | 0.0% | 0.05% | +6.4% |
| Q2 2019 | $1,050,000 | +2.1% | 12,820 | +1.4% | 0.05% | -11.3% |
| Q1 2019 | $1,028,000 | +22.4% | 12,639 | -1.0% | 0.05% | +8.2% |
| Q4 2018 | $840,000 | -0.7% | 12,762 | +16.3% | 0.05% | +14.0% |
| Q3 2018 | $846,000 | +4.8% | 10,978 | +0.4% | 0.04% | -2.3% |
| Q2 2018 | $807,000 | +13.8% | 10,935 | +0.3% | 0.04% | +10.0% |
| Q1 2018 | $709,000 | +1.6% | 10,906 | +1.0% | 0.04% | 0.0% |
| Q4 2017 | $698,000 | +1.6% | 10,798 | -1.4% | 0.04% | -4.8% |
| Q3 2017 | $687,000 | +2.1% | 10,946 | -1.5% | 0.04% | -2.3% |
| Q2 2017 | $673,000 | +16.4% | 11,111 | -0.3% | 0.04% | +10.3% |
| Q1 2017 | $578,000 | +17.0% | 11,146 | 0.0% | 0.04% | +8.3% |
| Q4 2016 | $494,000 | -7.0% | 11,146 | 0.0% | 0.04% | -10.0% |
| Q3 2016 | $531,000 | +5.1% | 11,146 | -0.1% | 0.04% | +2.6% |
| Q2 2016 | $505,000 | +7.0% | 11,161 | -2.8% | 0.04% | +8.3% |
| Q1 2016 | $472,000 | +11.1% | 11,478 | +3.0% | 0.04% | +12.5% |
| Q4 2015 | $425,000 | +15.2% | 11,146 | -0.9% | 0.03% | +14.3% |
| Q3 2015 | $369,000 | -53.4% | 11,246 | -0.6% | 0.03% | -46.2% |
| Q2 2015 | $791,000 | +2.1% | 11,311 | 0.0% | 0.05% | 0.0% |
| Q1 2015 | $775,000 | -8.2% | 11,311 | -1.7% | 0.05% | -11.9% |
| Q4 2014 | $844,000 | +2.3% | 11,511 | +0.2% | 0.06% | -25.3% |
| Q3 2014 | $825,000 | -4.1% | 11,491 | -3.4% | 0.08% | -4.8% |
| Q2 2014 | $860,000 | -16.7% | 11,891 | -15.3% | 0.08% | -20.2% |
| Q1 2014 | $1,032,000 | +2.1% | 14,031 | -3.5% | 0.10% | -2.8% |
| Q4 2013 | $1,011,000 | -8.1% | 14,540 | -13.2% | 0.11% | -25.2% |
| Q3 2013 | $1,100,000 | -15.6% | 16,751 | -11.1% | 0.14% | -15.9% |
| Q2 2013 | $1,304,000 | – | 18,832 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |